Licopid / GMDP
6 indexed publications · 5 human studies · research from 1999 to 2020
Research goals studied
- Delivery & pharmacokinetics
- Gut & digestion
- Immune function
- Infection & antiviral
- Kidney, liver & organ
- Skin & tissue repair
Studies referencing Licopid / GMDP
LC-MS/MS Determination of Glucosaminylmuramyl Dipeptide and Application to a Human Pharmacokinetic Study
2020 · Human evidence
Developed a quantitative plasma assay and applied it to pharmacokinetic measurement.
Pathogenetic Therapy of Psoriasis by Muramyl Peptide
2019 · Human evidence
Evaluated glucosaminylmuramyl dipeptide in psoriasis with clinical and immune endpoints.
Licopid-Containing Immunomodulation in Helicobacter pylori-Associated Disease
2017 · Human evidence
Indexed clinical report involving Licopid in an H. pylori-related treatment regimen.
Complex Immunomodulating Treatment with Licopid
2002 · Human evidence
Clinical report involving Licopid in a combined immunomodulating regimen.
Licopid in the Combined Treatment of Pulmonary Tuberculosis
2002 · Human evidence
Historical clinical report of Licopid as adjunctive therapy in pulmonary tuberculosis.
Muramyl Peptides and the Immunomodulator Licopid: Clinical and Experimental Experience
1999 · Preclinical
Review of experimental and clinical experience with muramyl peptides and Licopid.
Working with Licopid / GMDP?
Convert a vial to draw volume on the peptide calculator, or track protocols and vials in the free app.
Start tracking free